Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Virtual Reality Utilizing RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use

NCT04010266 is registered in ClinicalTrials.gov with AppliedVR Inc. as lead sponsor.

NCT NCT04010266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04010266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Virtual Reality Utilizing RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use
Lead sponsor
AppliedVR Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2021
Completion date
August 31, 2023
Enrollment
63 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arthropathy of knee, opioid use, pain, postoperative